Vaccine X: review time and acceptance speed

ISSN 2590-1362 · Elsevier BV · Medicine

Half of the articles Vaccine X accepted in 2024 were accepted within 169 days of submission (n = 160); the middle half took 95–237 days.

Submission → acceptance (2024)
169 days median
middle half 95–237 · n = 160
Acceptance → online
2 days median
middle half 1–4 · n = 160
Change since 2022
Faster than 2022: the median fell from 208 to 169 days (90% CI -74 to -5 days).
Open access · fees
Open access (DOAJ) · $2,520

Accepted articles only · dates deposited by the publisher in PubMed · data as of Sep 15, 2026

Plan submissions to a deadline — free

How long does Vaccine X take to accept a paper?

days0751502253002022: middle half 129–272 days2082022n=1092023: middle half 101–271 days1592023n=1572024: middle half 95–237 days1692024n=160
Line = median; shaded box = middle half of articles (25th–75th percentile). Year of acceptance.
Days from submission to acceptance, by year of acceptance
YearArticles (n)25th pctMedian75th pct90th pctAccepted <14 daysHave a revised date
2024160951692371.9%94%
20231571011592711.3%97%
20221091292082720.0%96%

Distribution in 2024

0–29 days: 4% (6 articles)030–59 days: 6% (10 articles)3060–89 days: 10% (16 articles)6090–119 days: 16% (26 articles)90120–149 days: 9% (15 articles)120150–179 days: 8% (12 articles)150180–209 days: 14% (23 articles)180210–239 days: 8% (13 articles)210240–269 days: 5% (8 articles)240270–299 days: 4% (6 articles)270300–329 days: 2% (3 articles)300330–359 days: 4% (6 articles)330360+ days: 10% (16 articles)360+days from submission to acceptance (30-day bins)
Show as a table
DaysArticlesShare
0–2963.8%
30–59106.2%
60–891610.0%
90–1192616.2%
120–149159.4%
150–179127.5%
180–2092314.4%
210–239138.1%
240–26985.0%
270–29963.8%
300–32931.9%
330–35963.8%
360+1610.0%

From acceptance to online publication

After acceptance, half of the 2024 articles appeared online within 2 days (middle half 1–4 days, n = 160).

From submission to online publication, the median was 173 days (middle half 102–240 days, n = 160).

Read these numbers carefully

  • These times describe articles the journal accepted. Rejected manuscripts never appear in public data, so they cannot tell you how long a rejection takes.
  • Dates are the ones the publisher deposited with PubMed. Some publishers record the date a revised manuscript arrived as the submission date, which makes review look faster.
  • Invited articles and special issues can move faster than regular submissions.

Open access status and publishing fees

Open access (listed in DOAJ). Listed APC: $2,520 (DOAJ).

Institutions reported paying a median of about $1,968 per article (2023–2025, 16 reported payments in OpenAPC; converted from euros at yearly ECB average rates).

Many journals waive or reduce fees for authors from eligible countries or institutions with publishing agreements — check with the journal and your library.

Integrity and indexing signals

Facts from public records, shown without judgement. See the methodology for why each can be worth a closer look.

Listed in DOAJYes (DOAJ record)
Articles indexed for MEDLINE in 2024None found (the journal may be in PubMed through PubMed Central instead)
Retractions0 retracted articles among 481 added to PubMed in 2021–2025 (0.00 per 1,000), per the Retraction Watch Database.
Accepted within 14 days of submission1.9% of 2024 articles
Publication volume161 articles added to PubMed in 2024 (+5% vs 2023).

Topics and scope

Medicine journalsSocial Sciences journals

Similar journals — faster or cheaper, side by side

Journals publishing on the most similar topics (OpenAlex), ordered by similarity. Only 2024 figures are compared with the 2024 median of Vaccine X, 169 days.

Paid APC medianDOAJMEDLINE
Vaccines37 (2024, n = 1,407)≈$3,300$2,413 (104 payments)YesNo
Vaccine128 (2024, n = 948)≈$3,620$3,365 (37 payments)NoYes
npj Vaccines179 (2024, n = 235)$4,090$3,664 (18 payments)YesNo
Epidemiologia43 (2024, n = 55)≈$1,467YesNo
Public Health in Practice165 (2024, n = 116)$2,270YesNo
China CDC Weekly84 (2024, n = 255)NoNo
The Lancet Infectious Diseases44 (2024, n = 243)≈$7,280NoYes
The Lancet Regional Health - Western Pacific105 (2024, n = 245)$5,010$3,597 (5 payments)YesNo

Frequently asked questions

How long does Vaccine X take to accept a paper?

Half of the articles Vaccine X accepted in 2024 were accepted within 169 days of submission (n = 160); the middle half took 95–237 days. Based on dates in PubMed for accepted articles only.

How long after acceptance are Vaccine X articles published online?

Half of the articles accepted in 2024 appeared online within 2 days of acceptance (n = 160).

Does Vaccine X charge an article processing charge (APC)?

Listed APC: $2,520 (DOAJ).

Sources and method

Journal identity: ISSN-L 2590-1362; NLM ID 101748769; OpenAlex record. Speed figures use 160 articles accepted in 2024 with valid dates; excluded records for that year: none.

Spotted a problem with this journal's data, or are you the publisher? Report a correction or email rafiq@gradsummit.com. Verified errors are corrected within five business days.

Get the free Journal Submission Go/No-Go Checklist

The pre-submission checks from Write and Publish a Scientific Paper: journal fit, formatting, cover letter and reviewer suggestions. We’ll email you the download link.

One email with your download, then occasional research tips. One-click unsubscribe, anytime. We never sell your data.

Get Write and Publish a Scientific Paper

Data sources. Submission, acceptance and publication dates: Courtesy of the U.S. National Library of Medicine (PubMed, entries through Sep 15, 2026). NLM does not endorse Journal Clock, and these figures may not reflect the most current PubMed data. Journal fees and open-access listing: DOAJ (CC0, retrieved Sep 16, 2026). Fees paid by institutions: OpenAPC (Open Database License, retrieved Sep 16, 2026). Retractions: Retraction Watch Database via Crossref (retrieved Sep 16, 2026). Journal identifiers and topics: OpenAlex (CC0). Currency conversion: ECB reference rates (Sep 15, 2026). How these numbers are calculated · For organisations.